Orange Book product · Brand (NDA)
ANAFRANIL
CLOMIPRAMINE HYDROCHLORIDE
At a glance
Dec 29, 1989
Approved
Brand (NDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 29, 1989
37 yr ago
Today
Pharmaceutical detail
Active ingredient
CLOMIPRAMINE HYDROCHLORIDE
Strength
25MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
NDA 019906
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2023CLOMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 216440 · AUROBINDO PHARMA
- 2021CLOMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 211822 · ALEMBIC
- 2020CLOMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213897 · AJANTA PHARMA LTD
- 2020CLOMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 212285 · UNIQUE
- 2020CLOMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213219 · MICRO LABS
- 2020CLOMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213221 · RK PHARMA
- 2020CLOMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 210653 · TP ANDA HOLDINGS
- 2020CLOMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 211364 · IXORA LIFESCIENCE
- 2019CLOMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 212218 · JUBILANT CADISTA
- 2019CLOMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 211767 · MANKIND PHARMA
- 2018CLOMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 209294 · LUPIN
- 2018CLOMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 208632 · AMNEAL PHARMS CO
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
